tiprankstipranks
Titan Medical (TSE:TMD)
TSX:TMD

Titan Medical (TMD) Income Statement

41 Followers

Titan Medical Income Statement

Last quarter (Q3 2023), Titan Medical's total revenue was $450.00K, an increase of Infinity% from the same quarter last year. In Q3, Titan Medical's net income was $68.00K. See Titan Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 17.13M-$ 20.09M$ 20.00M$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 17.13M-----
Operating Expense
$ 18.00M$ 44.77M$ 51.08M$ 15.85M$ 59.27M$ 39.69M
Operating Income
$ -867.00K$ -44.77M$ -30.99M$ 4.15M$ -59.27M$ -39.69M
Net Non Operating Interest Income Expense
$ -4.00K$ -3.00K$ 52.00K$ 2.88M$ -2.40M$ -1.02M
Other Income Expense
$ -1.35M$ -4.55M$ 16.24M$ -25.46M$ 19.76M$ 18.08M
Pretax Income
$ -1.93M$ -42.60M$ -14.80M$ -24.18M$ -41.91M$ -22.64M
Tax Provision
$ -56.00K$ -56.00K$ 56.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.87M$ -42.54M$ -14.86M$ -24.18M$ -41.91M$ -22.64M
Basic EPS
$ -0.02$ -0.38$ -0.14$ -0.36$ -1.37$ -1.36
Diluted EPS
$ -0.04$ -0.38$ -0.14$ -0.36$ -1.37$ -1.36
Basic Average Shares
$ 348.45M$ 111.52M$ 108.44M$ 67.01M$ 30.69M$ 16.64M
Diluted Average Shares
$ 373.00M$ 111.52M$ 108.44M$ 67.01M$ 30.69M$ 16.64M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----$ 58.06K$ 97.78K
Total Expenses
$ 18.00M$ 44.77M$ -51.08M$ -15.85M$ 59.27M$ 39.69M
Net Income From Continuing And Discontinued Operation
$ -1.87M$ -42.54M$ -14.86M$ -24.18M$ -41.91M$ -22.64M
Normalized Income
$ -2.55M$ -40.34M$ -10.88M$ -20.24M$ -61.67M$ -40.71M
Interest Expense
----$ 422.99K-
EBIT
$ -1.67M$ -42.45M$ -14.68M$ -23.09M$ -41.48M$ -39.69M
EBITDA
$ -1.28M$ -41.59M$ -13.98M$ -22.81M$ -41.45M$ -39.66M
Currency in USD

Titan Medical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis